Zhuhai United Laboratories Co. Ltd. – FDA 483, Sep 11, 2017
Zhuhai United Laboratories Co., Ltd., an API/Sterile Finished Drug Product Manufacturer in Zhuhai, China, was cited for significant deficiencies during an FDA inspection. The observations highlight severe data integrity issues, including the deletion and modification of raw electronic data, inadequate laboratory investigation procedures for out-of-specification results, and unscientific testing methods. Additionally, the firm failed to properly investigate deviations, maintain adequate controls over electronic systems, and ensure proper aseptic processing and visual inspection practices.
ID · 95386da9-cf10-48ec-8fef-708e00d879db
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.